Cervical Cancer Market

Sep 28, 2020

10 likes | 19 Views

In 2017, the total prevalent population of Cervical Cancer in 7MM was 43,514. The prevalent cases of Cervical Cancer in the United States in 2017 was 32.07% of the total prevalent cases. The therapeutic market of Cervical Cancer in the 7MM was found to be USD 330.59 million in 2017. Advancements in treatment, improvement in preventive measures, and early detection of disease are some of the key factors expected to drive the Cervical Cancer Market forward in the coming years. The key players in the Cervical Cancer Market includes Seattle Genetics, Genmab, AstraZeneca, Zeria Pharmaceutical, Regeneron Pharmaceutical, Sanofi, Advaxis, Iovance Biotherapeutics, Agenus, Roche, Akeso Biopharma, Vaccibody and Altor BioScience. For more detailed information on Cervical Cancer Market, visit: https://www.delveinsight.com/infographics/cervical-cancer-market

DelveInsight

Download Presentation

Cervical Cancer Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D